Back to top

Image: Bigstock

Hawkins Expands Texas Water Treatment With Eagle Labs Buyout

Read MoreHide Full Article

Key Takeaways

  • Hawkins adds two Eagle Labs locations, bringing its Texas Water Treatment facilities to seven.
  • HWKN gains expertise in coagulants and polymers plus established North Texas customer relationships.
  • A new Dallas-Fort Worth facility is expected to strengthen regional water treatment service capacity.

Hawkins, Inc. (HWKN - Free Report) has completed the acquisition of the assets of Eagle Labs, Inc., expanding its Water Treatment business into the Dallas–Fort Worth region of Texas. Eagle Labs distributes water treatment products directly to customers in Texas and has in-house manufacturing capabilities. 

The acquisition adds two locations in the Dallas–Fort Worth area, increasing Hawkins’ total Water Treatment facilities in Texas to seven. Hawkins first entered the Texas market in fiscal 2022. 

According to Hawkins, Eagle Labs brings expertise in coagulants and polymers, along with a customer service model that complements HWKN’s existing Water Treatment operations in the state. Eagle Labs has served North Texas and surrounding areas for more than 30 years, building relationships with local customers and communities. 

Hawkins has also opened a new facility in the Dallas–Fort Worth area. The company expects the new facility, together with the acquired Eagle Labs operations, to strengthen its ability to serve water treatment demand across the region. 

Price Performance of HWKN

Shares of HWKN are down 30.7% over the past year compared with the industry’s 0.9% decline.

Zacks Investment ResearchImage Source: Zacks Investment Research

HWKN’s Zacks Rank & Key Picks

HWKN currently carries a Zacks Rank #4 (Sell).

Some better-ranked stocks in the Basic Materials space are Ternium S.A. (TX - Free Report) , Avient Corporation (AVNT - Free Report) and Innospec Inc. (IOSP - Free Report) . TX and AVNT currently sport a Zacks Rank #1 (Strong Buy), while IOSP carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here. 

The Zacks Consensus Estimate for TX’s current-year earnings is $6.54 per share, implying a 201.4% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in two of the trailing four quarters and missed twice, with the negative average surprise being 11.1%.

The Zacks Consensus Estimate for AVNT’s current-year earnings is pegged at $3.2 per share, indicating a 13.5% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 3.4%.

The Zacks Consensus Estimate for IOSP’s current-year earnings has moved up 3.9% over the past 60 days. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 12.9%.

Published in